0001209191-15-048302.txt : 20150601 0001209191-15-048302.hdr.sgml : 20150601 20150601160959 ACCESSION NUMBER: 0001209191-15-048302 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150528 FILED AS OF DATE: 20150601 DATE AS OF CHANGE: 20150601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Viking Therapeutics, Inc. CENTRAL INDEX KEY: 0001607678 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461073877 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD, SUITE 50 CITY: SAN DIEGO STATE: CA ZIP: 92037 BUSINESS PHONE: 858-550-7810 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD, SUITE 50 CITY: SAN DIEGO STATE: CA ZIP: 92037 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37355 FILM NUMBER: 15903480 BUSINESS ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-05-28 0 0001607678 Viking Therapeutics, Inc. VKTX 0000886163 LIGAND PHARMACEUTICALS INC 11119 NORTH TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 0 0 1 0 Common Stock 2015-05-28 4 J 0 228105 0.00 A 4780964 D The shares of Common Stock were acquired as partial consideration for licenses granted to the Issuer by Ligand Pharmaceuticals Incorporated ("Ligand") pursuant to the Master License Agreement, dated May 21, 2014, among Ligand, Metabasis Therapeutics, Inc. ("Metabasis"), a wholly-owned subsidiary of Ligand, and the Issuer, as amended by the First Amendment to Master License Agreement, dated September 6, 2014 and the Second Amendment to Master License Agreement, dated April 8, 2015. Includes 55,060 shares acquired by Metabasis. Includes 882,474 shares held by Metabasis. /s/ Charles S. Berkman 2015-06-01